186 related articles for article (PubMed ID: 7650366)
1. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes.
D'Andrea A; Chang C; Franz-Bacon K; McClanahan T; Phillips JH; Lanier LL
J Immunol; 1995 Sep; 155(5):2306-10. PubMed ID: 7650366
[TBL] [Abstract][Full Text] [Related]
2. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
3. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
Bottino C; Sivori S; Vitale M; Cantoni C; Falco M; Pende D; Morelli L; Augugliaro R; Semenzato G; Biassoni R; Moretta L; Moretta A
Eur J Immunol; 1996 Aug; 26(8):1816-24. PubMed ID: 8765026
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
[TBL] [Abstract][Full Text] [Related]
5. The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.
Lanier LL; Gumperz JE; Parham P; Melero I; López-Botet M; Phillips JH
J Immunol; 1995 Apr; 154(7):3320-7. PubMed ID: 7897214
[TBL] [Abstract][Full Text] [Related]
6. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL.
Bakker AB; Phillips JH; Figdor CG; Lanier LL
J Immunol; 1998 Jun; 160(11):5239-45. PubMed ID: 9605119
[TBL] [Abstract][Full Text] [Related]
7. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
Vyas Y; Selvakumar A; Steffens U; Dupont B
Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs.
Storset AK; Slettedal IO; Williams JL; Law A; Dissen E
Eur J Immunol; 2003 Apr; 33(4):980-90. PubMed ID: 12672064
[TBL] [Abstract][Full Text] [Related]
9. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.
Morvan M; Willem C; Gagne K; Kerdudou N; David G; Sébille V; Folléa G; Bignon JD; Retière C
J Immunol; 2009 Jun; 182(11):6727-35. PubMed ID: 19454667
[TBL] [Abstract][Full Text] [Related]
11. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors.
Fan QR; Mosyak L; Winter CC; Wagtmann N; Long EO; Wiley DC
Nature; 1997 Sep; 389(6646):96-100. PubMed ID: 9288975
[TBL] [Abstract][Full Text] [Related]
12. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.
Gumperz JE; Valiante NM; Parham P; Lanier LL; Tyan D
J Exp Med; 1996 Apr; 183(4):1817-27. PubMed ID: 8666938
[TBL] [Abstract][Full Text] [Related]
14. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
[TBL] [Abstract][Full Text] [Related]
15. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
16. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer.
Pende D; Biassoni R; Cantoni C; Verdiani S; Falco M; di Donato C; Accame L; Bottino C; Moretta A; Moretta L
J Exp Med; 1996 Aug; 184(2):505-18. PubMed ID: 8760804
[TBL] [Abstract][Full Text] [Related]
17. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell recognition of HLA class I molecules.
Brooks AG; Boyington JC; Sun PD
Rev Immunogenet; 2000; 2(3):433-48. PubMed ID: 11256749
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
[TBL] [Abstract][Full Text] [Related]
20. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
Dorothée G; Echchakir H; Le Maux Chansac B; Vergnon I; El Hage F; Moretta A; Bensussan A; Chouaib S; Mami-Chouaib F
Oncogene; 2003 Oct; 22(46):7192-8. PubMed ID: 14562047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
